Loading…
Absci Corporation is projected to rise to $8.60 by 2027, a +67% move from its current price of $5.16. ABSI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.94 | $5.16 | $5.40 | +0.04% |
| May 30 | $4.85 | $5.16 | $5.50 | +0.07% |
| May 31 | $4.78 | $5.17 | $5.58 | +0.11% |
| Jun 1 | $4.72 | $5.17 | $5.65 | +0.14% |
| Jun 2 | $4.68 | $5.17 | $5.72 | +0.18% |
| Jun 3 | $4.63 | $5.17 | $5.77 | +0.21% |
| Jun 4 | $4.59 | $5.17 | $5.83 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.59 | $5.17 | $5.83 | +0.25% |
| Week 2 | $4.38 | $5.19 | $6.13 | +0.50% |
| Week 3 | $4.23 | $5.20 | $6.39 | +0.74% |
| Week 4 | $4.11 | $5.21 | $6.61 | +0.99% |
| Week 5 | $4.01 | $5.22 | $6.81 | +1.24% |
| Week 6 | $3.91 | $5.24 | $7.01 | +1.50% |
| Week 7 | $3.83 | $5.25 | $7.19 | +1.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Absci Corporation is a clinical-stage biopharmaceutical company that develops various antibody therapeutics in the United States.
Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology.
Absci has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corporation (ABSI) is a healthcare company currently trading at $5.10 per share, with a market capitalization of $795.12M and a rank of 2701.
The near-term price landscape is informed by a 30-day forecast that shows the average price for 2026 at $5.10, rising in subsequent years to values such as $8.31 in 2027, $9.42 in 2028, $10.75 in 2029, and $10.48 in 2030, with continued increases through 2050 when the average is $62.27. The forecast also provides a sequence of higher maximums, and the sentiment shifts from Neutral in 2026 to bullish thereafter.
A major floor 61.6% below — a decisive break under it would weaken the trend.
The nearest floor, 38.6% below — buyers have tended to step in here.
The nearest ceiling, 15.3% above — a clean break opens room to run.
A major ceiling 46.1% above — clearing it would confirm fresh momentum.
Key ABSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.12 | Buy | $5.14 | Buy |
| MA 10 | $5.11 | Buy | $5.14 | Buy |
| MA 20 | $5.28 | Sell | $5.01 | Buy |
| MA 50 | $4.08 | Buy | $4.36 | Buy |
| MA 100 | $3.49 | Buy | $3.86 | Buy |
| MA 200 | $3.39 | Buy | $3.55 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.14 | Neutral |
| Stoch RSI (14) | 24.95 | Neutral |
| CCI (20) | -25.65 | Neutral |
| Williams %R (14) | -58.27 | Info |
| MACD (12,26,9) | -0.11 | Sell |
| ROC (12) | -12.54 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 41.73 | Neutral |
| TRIX (15) | 1.34 | Buy |
| Awesome (5,34) | 0.50 | Buy |
| Ultimate (7,14,28) | 48.83 | Neutral |
| Momentum (10) | -0.20 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 5.21 | Sell |
| ADX (14) | 27.08 | Buy |
| ATR (14) | 0.20 | Info |
The 30-day range is $3.74 to $6.95, with the current price sitting within that band.
RSI14 is 60, the 50-day simple moving average is $3.97, and the 200-day simple moving average is $3.36. Support is at $3.05 and resistance at $5.95. The near-term picture carries a bullish tilt within a context of a broad trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.30 | $5.16 | $7.92 | 0% | Neutral | |
| $6.39 | $8.60 | $12.46 | +67% | Bullish | |
| $6.92 | $9.77 | $14.93 | +89% | Bullish | |
| $7.81 | $11.49 | $18.31 | +123% | Bullish | |
| $7.50 | $11.45 | $18.90 | +122% | Bullish | |
| $7.54 | $11.91 | $20.26 | +131% | Bullish | |
| $10.64 | $17.37 | $30.36 | +237% | Bullish | |
| $12.39 | $20.86 | $37.35 | +304% | Bullish | |
| $13.45 | $23.33 | $42.72 | +352% | Bullish | |
| $15.33 | $27.39 | $51.19 | +431% | Bullish | |
| $23.82 | $48.86 | $99.41 | +847% | Bullish | |
| $34.80 | $77.34 | $177.51 | +14.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.30 | $5.16 | $6.14 | +0.00% |
| June 2026 | $4.38 | $5.22 | $6.41 | +1.10% |
| July 2026 | $4.41 | $5.33 | $6.70 | +2.15% |
| August 2026 | $4.68 | $5.71 | $7.30 | +7.21% |
| September 2026 | $4.67 | $5.76 | $7.45 | +0.80% |
| October 2026 | $4.43 | $5.51 | $7.22 | -4.35% |
| November 2026 | $4.49 | $5.63 | $7.45 | +2.13% |
| December 2026 | $4.70 | $5.93 | $7.92 | +5.38% |
Click any year to see its month-by-month ABSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ABSI is projected to trade between $2.30 and $7.92, averaging $5.16 — a potential gain of 0% from today's $5.16. Price action looks broadly range-bound.
Absci Corporation's 2027 outlook centres on $8.60, within a $6.39 to $12.46 range. That is up +67% on the projected 2026 average. That marks a +67% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ABSI could reach as high as $14.93, with a base case around $9.77 and support toward $6.92 — roughly +89% from $5.16. Momentum favours further upside here.
Expect ABSI to range from $7.81 to $18.31 through 2029. The $11.49 average target implies a +123% move from current prices. That is up +18% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ABSI price prediction for 2030 points to an average of $11.45 (low $7.50, high $18.90) — a potential gain of +122% on today's $5.16. Momentum favours further upside here.
In 2031, ABSI is projected to trade between $7.54 and $20.26, averaging $11.91 — a potential gain of +131% from today's $5.16. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Absci Corporation's 2032 outlook centres on $17.37, within a $10.64 to $30.36 range. That is up +46% on the projected 2031 average. That marks a +237% change versus current levels. Momentum favours further upside here.
By 2033, ABSI could reach as high as $37.35, with a base case around $20.86 and support toward $12.39 — roughly +304% from $5.16. Buyers look set to stay in control over this stretch.
Expect ABSI to range from $13.45 to $42.72 through 2034. The $23.33 average target implies a +352% move from current prices. That is up +12% on the projected 2033 average. Momentum favours further upside here.
The ABSI price prediction for 2035 points to an average of $27.39 (low $15.33, high $51.19) — a potential gain of +431% on today's $5.16. Buyers look set to stay in control over this stretch.
In 2040, ABSI is projected to trade between $23.82 and $99.41, averaging $48.86 — a potential gain of +847% from today's $5.16. That is up +78% on the projected 2035 average. Momentum favours further upside here.
Absci Corporation's 2050 outlook centres on $77.34, within a $34.80 to $177.51 range. That is up +58% on the projected 2040 average. That marks a +14.0x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABSI today (≈ 193.79845 ABSI) could be worth
$14,988.97
+$13,988.97 (+1399%) by 2050 · US Dollar
Based on the average projected ABSI price of $77.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABSIwould be worth at today's price.
$1,000 invested in ABSI on May 27, 2025 (≈ 367.647055 ABSI) would be worth
$1,897.06
+$897.06 (+89.7%) today · 1.90× · US Dollar
Based on a ABSI entry price of $2.72 vs. today's $5.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.95 | $1,042.42 | +4.2% |
| 1 month ago | $4.85 | $1,063.92 | +6.4% |
| 3 months ago | $2.81 | $1,836.3 | +83.6% |
| 6 months ago | $3.17 | $1,627.76 | +62.8% |
| 1 year ago | $2.72 | $1,897.06 | +89.7% |
| All time (4.8y) ago | $21.59 | $239 | -76.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABSI forecast.
Our base-case forecast reaches $10.00 around 2029.
Implied market cap at $10.00: $1.56B
Looking further out, the forecast depicts a strong rise in expected averages and substantial upside across years. The 2026 average is $5.10 with a 0% ROI and Neutral sentiment, followed by a sequence of higher averages in successive years: 2027 avg $8.31 (ROI 63, Bullish), 2028 avg $9.42 (ROI 84.7, Bullish), 2029 avg $10.75 (ROI 110.9, Bullish), 2030 avg $10.48 (ROI 105.5, Bullish), 2031 avg $10.86 (ROI 112.9, Bullish).
In the early-to-mid 2030s, the averages rise further: 2032 avg $15.44 (ROI 202.8, Bullish), 2033 avg $18.33 (ROI 259.5, Bullish), 2034 avg $20.72 (ROI 306.3, Bullish), 2035 avg $24.12 (ROI 372.9, Bullish).
Longer term, the forecast shows substantial upside: 2040 avg $41.78 (ROI 719.1, Bullish) and 2050 avg $62.27 (ROI 1121, Bullish). These are estimates, not guarantees. The outlook remains bullish across the long horizon, but investors should consider uncertainty and the inherent limits of forecasted figures.
Tap a question to reveal the answer.
The 2030 forecast lists an avg price of $10.48, with a min of $6.76 and a max of $17.55, and a forecasted ROI of 105.5% with bullish sentiment.
The 2026 forecast is Neutral with an avg of $5.10 and a 0% ROI, while 2027 onward shows Bullish sentiment with rising averages and higher ROIs (e.g., 63% in 2027, up to 1121% by 2050). These are estimates, not guarantees.
Yes. The 2034 forecast lists an avg of $20.72 and a max of $38.59, with a min of $11.66.
Current price is $5.10 and market capitalization is $795.12M, with a market-rank of 2701.
Category Healthcare.
Absci Corporation Community Discussion
0Share your Absci Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.